These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2148194

  • 1. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [Abstract] [Full Text] [Related]

  • 4. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Oct; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 5. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T, Westlie L, Daae L, Vatle S.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 9. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 11. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 12. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
    Talseth T, Westlie L, Daae L.
    Am Heart J; 1991 Jan; 121(1 Pt 2):280-5. PubMed ID: 1824651
    [Abstract] [Full Text] [Related]

  • 13. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH, Cox DA, Himanen P, Huttunen M, Pitkäjärvi T, Pörsti P, Pöyhönen L, Pyykönen ML, Reinikainen P, Salmela P.
    Am J Cardiol; 1987 May 29; 59(14):61G-67G. PubMed ID: 2884854
    [Abstract] [Full Text] [Related]

  • 14. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan 29; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 15. An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency.
    Anderton JL, Notghi A.
    J Hum Hypertens; 1990 Oct 29; 4 Suppl 3():52-7. PubMed ID: 2148196
    [Abstract] [Full Text] [Related]

  • 16. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Lijnen P, Fagard R, Staessen J, Lissens W, Amery A.
    J Cardiovasc Pharmacol; 1989 Aug 29; 14(2):319-25. PubMed ID: 2476608
    [Abstract] [Full Text] [Related]

  • 17. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
    Holtzman JL, Kaihlanen PM, Rider JA, Lewin AJ, Spindler JS, Oberlin JA.
    Arch Intern Med; 1988 Mar 29; 148(3):539-43. PubMed ID: 3277569
    [Abstract] [Full Text] [Related]

  • 18. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
    Frick MH, Halttunen P, Himanen P, Huttunen M, Pörsti P, Pitkäjärvi T, Pöyhönen L, Pyykönen ML, Reinikainen P, Salmela P.
    Br J Clin Pharmacol; 1986 Mar 29; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
    [Abstract] [Full Text] [Related]

  • 19. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A, Daae LN, Kierulf P, Brusletto B, Holme I, Syvertsen JO.
    J Hypertens Suppl; 1990 Sep 29; 8(5):S41-6. PubMed ID: 1981076
    [Abstract] [Full Text] [Related]

  • 20. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
    Searle M, Dathan R, Dean S, Christensen CC, Westheim A.
    Eur J Clin Pharmacol; 1990 Sep 29; 39(3):299-300. PubMed ID: 2147909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.